M&A news

IDEXX Acquires CoVet to Advance AI

IDEXX Acquires CoVet to Advance AI

AcquisitionTechnology, Information and MediaCA

Get the full CoVet company profile

Access contacts, investors, buying signals & more

Open in Dashboard
CoVet logo
Acquired

CoVet

CanadaTechnology, Information and Media

Undisclosed amount

September 16, 2026

IDEXX logo
Acquirer

IDEXX

Biotechnology Research

IDEXX has acquired CoVet for an undisclosed amount. CoVet is an AI-powered assistant developed by veterinary professionals to simplify clinic operations and reduce administrative burdens. Its platform, informed by decades of hands-on experience from an in-house medical team, is context-aware and adapts to the specific requirements of general practice, specialty, and large-animal medicine. CoVet provides enterprise-grade performance and privacy compliance, serving practices ranging from solo DVMs to global veterinary groups.

The acquisition brings CoVet’s automation and intuitive design capabilities into IDEXX’s portfolio. CoVet empowers veterinary teams to approach each exam more prepared and confident that every step is complete. This allows professionals to dedicate more time to patient care by streamlining administrative processes. The strategic rationale behind this acquisition centers on enhancing operational efficiency and supporting veterinary practices with advanced technological tools.

The integration of CoVet’s AI-driven solutions with IDEXX’s existing offerings is anticipated to create a more comprehensive suite of tools for the veterinary industry. This combination aims to improve workflow, optimize practice management, and further reduce the administrative load on veterinary staff. The synergy is expected to deliver enhanced value to clinics seeking to modernize their operations and improve overall service delivery.

The unified entity will concentrate on advancing innovative solutions that empower veterinary professionals. The focus will remain on supporting the veterinary community with technology that simplifies daily tasks, allowing practitioners to prioritize patient well-being and clinical excellence.

No buying signals identified yet.

Unlock GTM signals

Discover CoVet's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at CoVet.

Unlock decision-makers
IDEXX Acquires CoVet to Advance AI | M&A News | Signalbase